https://glenmarkpharma-us.com/
Glenmark Pharmaceuticals U.S. – Glenmark Pharma is discovering advanced therapies for a new world.
https://health.economictimes.indiatimes.com/news/pharma/glenmark-pharmaceuticals-receives-anda-approval-for-lacosamide-tablet/90344777
Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablet, ETHealthworld
Glenmark: The company plans to launch the product in the US market immediately.
glenmarkpharmaceuticalsreceivesandaapproval
https://health.economictimes.indiatimes.com/news/pharma/glenmark-launches-akynzeo-i-v-for-preventing-chemotherapy-induced-nausea/97241967
Glenmark Pharmaceuticals Ltd: Glenmark launches AKYNZEO I.V. for preventing chemotherapy induced...
Glenmark Pharmaceuticals Ltd: AKYNZEO I.V. is a fixed dose combination of fosnetupitant (235 mg) and palonosetron (0.25 mg), and is available as a...
glenmark pharmaceuticals ltdlaunches
https://www.pymnts.com/cpi-posts/merck-glenmark-must-face-antitrust-trial-over-drug-pricing/
Merck, Glenmark Must Face Antitrust Trial Over Drug Pricing | PYMNTS.com
Feb 13, 2023 - Two large Pharma companies must face antitrust suit over generic delays. Merck and Glenmark Pharmaceuticals are headed for an antitrust trial over claims they...
drug pricingmerckglenmarkmustface
https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/glenmark-launches-antibacterial-solution-vancomycin-hydrochloride-in-us/119853602
Glenmark Pharmaceuticals: Glenmark launches antibacterial solution Vancomycin Hydrochloride in US,...
Glenmark Pharmaceuticals: The launched version is therapeutically equivalent to the reference listed drug, of Mylan Laboratories which in the last annual has...
glenmarkpharmaceuticalslaunchesantibacterialsolution
https://health.economictimes.indiatimes.com/news/pharma/drug-makers-glenmark-sun-pharma-dr-reddys-recall-products-in-us/93554706
Pharmaceuticals: Drug makers Glenmark, Sun Pharma, Dr Reddy's recall products in US, ETHealthworld
Pharmaceuticals: As per the US health regulator, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause...
https://www.business-standard.com/amp/markets/capital-market-news/glenmark-pharmaceuticals-reports-consolidated-net-profit-of-rs-347-96-crore-in-the-december-2024-quarter-125021500316_1.html
Glenmark Pharmaceuticals reports consolidated net profit of Rs 347.96 crore in the December 2024...
Sales rise 34.21% to Rs 3301.90 crore
https://health.economictimes.indiatimes.com/news/pharma/glenmark-launches-fdc-asthma-medication-in-india/92247274
Glenmark launches FDC asthma medication in India, ETHealthworld
Fdc: The novel fixed-dose combination will help in the management of uncontrolled asthma by improving lung function, symptom control, and reducing...
asthma medicationin indiaglenmarklaunchesfdc
https://health.economictimes.indiatimes.com/news/pharma/glenmark-pharma-gets-usfda-nod-for-generic-drug/78743390
Glenmark Pharma gets USFDA nod for generic drug, ETHealthworld
The company's US-based subsidiary has received final approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of PF...
glenmark pharmageneric druggetsusfdanod
https://health.economictimes.indiatimes.com/news/pharma/glenmark-pharma-launches-pulmonary-fibrosis-treatment-drug-in-india/78654036
Glenmark Pharmaceuticals: Glenmark Pharma launches pulmonary fibrosis treatment drug in India,...
Glenmark Pharmaceuticals: This will provide patients a far more cost-effective treatment option, and enable doctors to treat a wider patient population in the...
pulmonary fibrosisglenmarkpharmaceuticalslaunchestreatment
https://www.prnewswire.com/news-releases/glenmark-pharmaceuticals-initiates-clinical-investigation-for-gbr-310-its-proposed-biosimilar-candidate-for-xolair-300444887.html
Glenmark Pharmaceuticals Initiates Clinical Investigation for GBR 310, its Proposed Biosimilar...
/PRNewswire/ -- Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) cleared the...
clinical investigationglenmarkpharmaceuticalsinitiates
https://onkoportal.cz/
Glenmark Akademie | Edu
glenmarkakademie
https://glenmarkindia.com/
Home - Glenmark India
Apr 9, 2025 - 2nd* fastest growing companies amongstthe top 15 players in the Indian Pharmaceutical Market (IPM). Ranked 2nd in Dermatology and3rd in Respiratory Segments in...
glenmarkindia
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/glenmark-pharma-eyes-usd-80mn-from-ryaltris-sales-next-year/107932887
Glenmark Pharmaceuticals: Glenmark Pharma eyes USD 80mn from Ryaltris sales next year, ETHealthworld
Glenmark Pharmaceuticals: The drug firm has so far commercialised the product in 31 geographies across the globe.
https://health.economictimes.indiatimes.com/news/industry/glenmark-concludes-hypertension-awareness-month-in-india/91815352
Glenmark concludes Hypertension Awareness Month in India, ETHealthworld
Glenmark: Organised more than 110 public awareness rallies and 8000 screening camps to create mass awareness around hypertension.
awareness monthin indiaglenmarkconcludeshypertension
https://www.prnewswire.com/in/news-releases/glenmark-specialty-s-a-receives-approval-for-conducting-phase-1-clinical-trial-of-its-novel-molecule-grc-54276-in-patients-with-advanced-solid-tumors-and-hodgkin-s-lymphoma-836623412.html
Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical Trial of its Novel...
- GRC 54276 is one of the many novel molecules from Glenmark's resident, Innovative Medicines Group, specializing in the development of novel molecular...
https://pharma.economictimes.indiatimes.com/news/pharma-industry/zydus-and-glenmark-ceos-appointed-as-ipa-leaders/124293359
IPA New Leadership: Zydus and Glenmark CEOs appointed as IPA leaders, ETPharma
IPA New Leadership: Zydus Lifesciences and Glenmark CEOs appointed as the new President and Vice President of IPA, leading the Indian Pharmaceutical Alliance...
new leadershipipazydus
https://pharma.economictimes.indiatimes.com/news/pharma-industry/glenmark-recalls-product-in-us-over-manufacturing-issue-usfda/124700035
Glenmark Recalls Product in US Due to Manufacturing Issue: USFDA, ETPharma
Glenmark Pharmaceuticals: Glenmark is recalling a product in the US over a manufacturing issue as reported by the USFDA. The affected lot of Viorele,...
in usdue toglenmarkrecallsproduct
https://cfo.economictimes.indiatimes.com/tag/glenmark+pharma
Glenmark pharma - Latest glenmark pharma , Information & Updates - CFO -ETCFO
ETCFO.com brings latest glenmark pharma news, views and updates from all top sources for the Indian CFO industry.
glenmark pharmalatest informationupdatescfo
https://economictimes.indiatimes.com/glenmark-pharmaceuticals-ltd/stocks/companyid-4255.cms
Glenmark Pharma Share Price Today, Glenmark Pharma Stock Price Live NSE/BSE Updates | The Economic...
Glenmark Pharma Share Price Today - Get live NSE/BSE quotes of Glenmark Pharma with latest news, headlines and quick analysis. View forecasts, quarterly...
glenmark pharmashare price
https://manufacturing.economictimes.indiatimes.com/news/life-sciences/major-us-recall-glenmark-granules-and-other-drugmakers-address-manufacturing-issues/124215829
Major US recall: Glenmark, Granules, and other drugmakers address manufacturing issues,...
Drug Recall: Manufacturing problems led to these voluntary recalls. Glenmark's Azelaic Acid Gel tubes showed gritty texture. This Class II recall began on...
and othermajorusrecallglenmark
https://www.business-standard.com/article/companies/usfda-issues-warning-letter-to-glenmark-pharma-for-lapses-at-goa-plant-122121100277_1.html
USFDA issues warning letter to Glenmark Pharma for lapses at Goa plant | Company News - Business...
The US health regulator has pulled up drug maker Glenmark Pharmaceuticals for manufacturing lapses, including failure to establish required laboratory control...
https://www.glenmarkholding.com/
Glenmark
glenmark
https://health.economictimes.indiatimes.com/news/industry/glenmark-pharma-signs-rohit-sharma-as-brand-ambassador/81343275
Glenmark Pharmaceuticals Ltd.: Glenmark Pharma signs Rohit Sharma as brand ambassador, ETHealthworld
Glenmark Pharmaceuticals Ltd.: Rohit Sharma has "officially signed on to represent Glenmark's Candid Powder, a legacy brand of the company's consumer care...
glenmark pharmaceuticals ltdrohit sharmaas brandsigns
https://economictimes.indiatimes.com/prime/primeshots/4-insights-to-kick-start-your-day-featuring-glenmark-finally-sealing-the-deal/primearticleshow/103913912.cms?from=mdr
api: 4 insights to kick-start your day, featuring Glenmark finally sealing the deal - The Economic...
In Primeshots today: Glenmark sells stake in subsidiary; Good news for semiconductors; Alibabas logistics IPO; and Bank Niftys volatility.
https://glenmarkpharma.ca/
Glenmark Pharmaceutical, Canada
glenmarkpharmaceuticalcanada
https://www.prnewswire.com/news-releases/ichnos-glenmark-innovation-igi-and-abbvie-announce-exclusive-global-licensing-agreement-for-isb-2001-a-first-in-class-cd38ObcmaOcd3-trispecific-antibody-302502601.html
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB...
/PRNewswire/ -- IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie (NYSE: ABBV) today...
https://health.economictimes.indiatimes.com/news/pharma/glenmark-joins-hands-with-bausch-to-commercialise-nasal-spray-in-canada/81630088
Glenmark joins hands with Bausch to commercialise nasal spray in Canada, ETHealthworld
Nasal Spray: Under the terms of the pact, Glenmark will be responsible for regulatory approvals and supply of Ryaltris for the Canadian market and Bausch...
https://glenmarkpharma.se/
Home | Glenmark
Glenmark Pharmaceuticals Limited is a leading research-based pharmaceutical company. We are focused on developing and marketing branded and generic formulations
glenmark
https://health.economictimes.indiatimes.com/news/pharma/glenmark-gets-usfda-nod-for-generic-lung-cancer-drug/83837142
Us Food And Drug Administration: Glenmark gets USFDA nod for generic lung cancer drug, ETHealthworld
Us Food And Drug Administration: The company's product is the generic version of Boehringer Ingelheim Pharmaceuticals Inc's Ofev capsules.
food and drug administration
https://www.ibtimes.co.uk/indias-glenmark-eyes-big-deals-west-biologics-1430199
India's Glenmark Eyes Big Deals in West with Biologics | IBTimes UK
Dec 24, 2013 - Company recently won more than $200m selling rights to its drugs.
big deals
https://legal.economictimes.indiatimes.com/news/regulators/nirma-gets-cci-for-acquisition-of-majority-stake-in-glenmark-life-sciences/106132964
Nirma Ltd: Nirma gets CCI for acquisition of majority stake in Glenmark Life Sciences, ETLegalWorld
The Competition Commission of India (CCI) on Tuesday said it cleared Nirma's acquisition of majority shareholding of Glenmark Life Sciences Ltd. The...
https://myworldthrumycameralens.blogspot.com/2013/02/st-pauls-glenmark.html
photographing New Zealand: st paul's glenmark
Photos of New Zealand to entice you to visit.
new zealandst paulphotographingglenmark
https://www.prnewswire.com/news-releases/ichnos-glenmark-innovation-igi-and-abbvie-announce-exclusive-global-licensing-agreement-for-isb-2001-a-first-in-class-cd38ObcmaOcd3-trispecific-antibody-302502574.html
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB...
/PRNewswire/ -- IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie (NYSE: ABBV) today...
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/glenmark-specialty-sa-signs-license-agreement-with-jiangsu-alphamab-3d-medicines-for-envafolimab/107141838
Glenmark Specialty SA signs license agreement with Jiangsu Alphamab, 3D Medicines for Envafolimab,...
Under the terms of the agreement, GSSA will receive from Jiangsu Alphamab and 3DMed, an exclusive license to develop, register, commercialise, Envafolimab for...
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/domestic-formulations-biz-expected-to-grow-9-10-pc-over-next-decade-glenmark/113163979
Domestic formulations biz expected to grow 9-10 pc over next decade: Glenmark, ETHealthworld
"It is projected that the domestic formulations market will maintain a compound annual growth rate (CAGR) of 9-10 per cent over the next decade," the...
https://www.business-standard.com/amp/markets/capital-market-news/glenmark-life-drops-after-q4-pat-slides-33-yoy-to-rs-98-cr-generic-api-biz-down-8-yoy-124042500687_1.html
Glenmark Life drops after Q4 PAT slides 33% YoY to Rs 98 cr; Generic API biz down 8% YoY | Capital...
Glenmark Life Sciences tumbled 8.16% to Rs 758.80 after the company's consolidated net profit declined 33.09% to Rs 97.93 core in Q4 FY24 as compared with Rs...
https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/glenmark-launches-sodium-bicarbonate-injection-in-us/125078688
Glenmark Pharmaceuticals: Glenmark launches sodium bicarbonate injection in US, ETPharma
Glenmark Pharmaceuticals: The drug is indicated to treat severe metabolic acidosis and in the US over the last 12-months, till August this year it has an...
sodium bicarbonatein usglenmarkpharmaceuticalslaunches
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glenmark-pharmaceuticals-limited-582701-10032019
Glenmark Pharmaceuticals Limited - 582701 - 10/03/2019 | FDA
CGMP/Finished Pharmaceuticals/Adulterated
glenmarkpharmaceuticalslimitedfda
https://brandequity.economictimes.indiatimes.com/news/business-of-brands/usfda-gives-exception-to-glenmark-pharma-to-supply-pneumonia-drug-from-baddi-facility/97392744
Us Food And Drug Administration: USFDA gives exception to Glenmark Pharma to supply pneumonia drug...
Us Food And Drug Administration: Glenmark Pharmaceuticals Ltd on Friday said the US health regulator has provided an exception, enabling it to supply...
food and drug administration
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-usfda-nod-for-skin-lesion-treatment-gel/articleshow/54330409.cms
Glenmark gets USFDA nod for skin lesion treatment gel - The Economic Times
The company's current portfolio consists of 110 products authorised for distribution in the US marketplace and 61 Abbreviated New Drug Applications (ANDAs)...
skin lesion treatment
https://www.financialexpress.com/market/glenmark-pharmaceuticals-ltd-share-price/?ref=articlehyperlinking
Glenmark Pharmaceuticals Share Price Today: Glenmark Pharmaceuticals Stock Price Live NSE/BSE,...
Glenmark Pharmaceuticals Share Price Today (17th May, 2026): Check Glenmark Pharmaceuticals Stock Price live NSE/BSE on financialexpress.com. Get Glenmark...
share priceglenmarkpharmaceuticalstodaystock
https://brandequity.economictimes.indiatimes.com/news/business-of-brands/glenmark-eyes-double-digit-revenue-growth-in-fy24/103570208
Glenmark eyes double-digit revenue growth in FY24, ETBrandEquity
Glenmark: "For the new financial year, we aim to grow by 10-11 per cent in revenues, expand our EBITDA margin to 19-20 per cent, and continue to focus on...
double digitrevenue growthglenmarkeyes
https://theglenmarkhotel.com/
The Glenmark Hotel | The Glenmark Hotel
glenmarkhotel
https://glenmarkpharma.pl/
Home - Glenmark Pharmaceuticals
glenmarkpharmaceuticals
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/lupin-glenmark-recall-drugs-in-us-market-usfda/109190866
Lupin, Glenmark recall drugs in US market: USFDA, ETHealthworld
Us Food And Drug Administration: India has the highest number of USFDA compliant companies with plants outside of the USA. As per the fiscal year, 2022 report...
in uslupinglenmarkrecalldrugs
https://health.economictimes.indiatimes.com/news/pharma/glenmark-launches-triple-fdc-of-teneligliptin-with-pioglitazone-metformin-in-india/96404494
Glenmark launches triple FDC of Teneligliptin with Pioglitazone, Metformin in India, ETHealthworld
Glenmark: Launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained...
https://www.business-standard.com/article/pti-stories/glenmark-pharma-gets-usfda-nod-for-cholesterol-lowering-drug-119062800287_1.html
Glenmark Pharma gets USFDA nod for cholesterol lowering drug
Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for Ezetimibe and Simvastatin tablets, used for treating high...
glenmark pharmacholesterol loweringgetsusfdanod
https://economictimes.indiatimes.com/markets/stocks/news/will-the-launch-of-favipiravir-mark-the-turnaround-for-glenmark-pharma/articleshow/76498902.cms?from=mdr
favipiravir: Will the launch of Favipiravir mark the turnaround for Glenmark Pharma? - The Economic...
If the drug proves to be efficacious for Covid treatment, Glenmark will cash in on first mover advantage.
the launchglenmark pharmafavipiravir
https://www.business-standard.com/markets/capital-market-news/glenmark-pharmaceuticals-ltd-eases-for-fifth-straight-session-124111800529_1.html
Glenmark Pharmaceuticals Ltd eases for fifth straight session | Capital Market News - Business...
Glenmark Pharmaceuticals Ltd is quoting at Rs 1526.05, down 0.5% on the day as on 13:19 IST on the NSE. The stock jumped 94.35% in last one year as compared to...
glenmark pharmaceuticals ltdcapital market news
https://pharma.economictimes.indiatimes.com/news/regulatory-update/glenmark-biocon-units-recall-products-in-us-usfda/120184262
Glenmark, Biocon units recall products in US: USFDA, ETPharma
New Jersey-based Glenmark Pharmaceuticals Inc is recalling 8,160 bottles of chlorpromazine hydrochloride tablets in the US for "CGMP deviations", USFDA stated.
in usglenmarkbioconunitsrecall
https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/glenmark-launches-generic-ophthalmic-solution-in-us-market/118236509
Ophthalmic Products: Glenmark launches generic ophthalmic solution in US market, ETPharma
Ophthalmic Products: According to IQVIA, sales data for the 12-month period ending December 2024, the Xalatan Ophthalmic Solution achieved annual sales of...
ophthalmic productsin usglenmarklaunchesgeneric
https://health.economictimes.indiatimes.com/news/pharma/financial-performance/indias-glenmark-pharma-q1-profit-drops-on-higher-expenses/102670368
Glenmark Pharmaceuticals Ltd: India's Glenmark Pharma Q1 profit drops on higher expenses,...
Glenmark Pharmaceuticals Ltd: Consolidated net profit fell to 1.50 billion rupees ($18.12 million) for the three months ended June 30, from 1.93 billion rupees...
glenmark pharmaceuticals ltd
https://www.business-standard.com/companies/results/glenmark-life-sciences-q1fy24-results-net-profit-up-24-5-to-rs-135-4-cr-123072100448_1.html
Glenmark Life Sciences Q1FY24 results: Net profit up 24.5% to Rs 135.4 cr | Company Results -...
Glenmark Lifesciences Q1 Results: The company's revenue from operations rose 18.08% to Rs 578.4 crore from Rs 489.8 crore in the quarter that ended on June 30
https://economictimes.indiatimes.com/markets/stocks/news/stock-radar-glenmark-pharma-stock-retreats-from-march-2026-record-highs-time-to-buy-the-dip/articleshow/129755272.cms
Stock Radar: Glenmark Pharma stock retreats from March 2026 record highs; time to buy the dip? -...
Glenmark Pharmaceuticals stock shows signs of a comeback. It is trading above key support levels. Experts suggest buying for a target above Rs 2,500. The stock...
https://www.financialexpress.com/latest-updates/glenmark-settles-patent-suit-with-forest-lab-over-savella-drug/182096/
Glenmark settles patent suit with Forest Lab over Savella drug - Latest Updates News | The...
Glenmark will have the option to market and distribute its milnacipran hydrochloride tablets or an authorised generic version of Savella tablets
https://pharma.economictimes.indiatimes.com/news/mergers-and-acquisitions/glenmark-partners-with-beigene-for-launching-innovative-oncology-medicines-in-india/110330877
Glenmark partners with BeiGene for launching innovative oncology medicines in India, ETPharma
Under this collaboration, Glenmark will be responsible for development, registration and distribution of drugs along with providing access to BeiGene's...
https://www.prnewswire.com/apac/news-releases/glenmark-pharmaceuticals-launches-pioneering-nutrition-program-to-fight-malnutrition-in-the-philippines-302410606.html
Glenmark Pharmaceuticals Launches Pioneering Nutrition Program to Fight Malnutrition in the...
/PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures...
nutrition programfight malnutritionglenmarkpharmaceuticalslaunches
https://glenmark-pharma.pl/
Strona domeny glenmark-pharma.pl
glenmark pharmastronadomenypl
https://health.economictimes.indiatimes.com/news/pharma/glenmark-receives-us-fda-nod-for-first-in-human-clinical-study-of-patients-with-advanced-solid-tumors-and-lymphomas/98698064
Glenmark receives US FDA nod for first-in-human clinical study of patients with advanced solid...
Glenmark: GRC 54276, an orally available, small-molecule hematopoietic progenitor kinase 1 (HPK1) inhibitor, is being tested to assess its efficacy for...
https://www.business-standard.com/companies/news/glenmark-life-sciences-q3-profit-rises-to-rs-119-cr-api-biz-up-6-4-124012300705_1.html
Glenmark Life Sciences Q3 profit rises to Rs 119 cr, API biz up 6.4% | Company News - Business...
The Mumbai-based company, which detergent maker Nirma is in the process of taking over, said its profit rose to 1.19 billion rupees ($14.32 million) in the...